
Lumos Diagnostics continues to expand its commercial footprint through FDA clearance, growing U.S. adoption, manufacturing partnerships, and paediatric research. The company now focuses on turning regulatory success and market access into recurring sales, broader reimbursement, and sustainable long-term growth.

EchoIQ is expanding its US presence through new funding, partnerships, clinical research, and hospital deployments. Its AI-based cardiac software continues to gain commercial traction, while the chart shows a pullback to key support within a longer-term rising trend.
.webp&w=828&q=75)
Wildcat Resources (ASX: WC8) advances its Pilbara lithium portfolio with expanding high-grade discoveries, a progressing DFS at Tabba Tabba, and strong cash reserves, positioning the company for transformational growth amid rising global lithium demand.

Resolution Minerals is advancing U.S. critical minerals projects through drilling, permitting progress and strategic partnerships. Its Horse Heaven Project targets antimony, tungsten and gold, supported by government engagement, funding and expanding exploration activities.

St George Mining is a pre-revenue critical-minerals explorer advancing its 100%-owned Araxá rare earths-niobium project in Brazil. Resource growth, funding, studies and potential partnerships offer upside, while dilution, execution and commodity-price risks remain material
.webp&w=828&q=75)
VHM Limited (ASX: VHM) advances its Tier‑1 Goschen critical minerals project toward FID, backed by full permitting, government financing interest, expanded resources and strategic offtake optionality. Strong regulatory momentum and project scale position VHM for a major rerating